1-9 of 9
Authors: Karine Lacombe
Journal Article
Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study—IMEA 055
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 3, March 2023, Pages 769–778, https://doi.org/10.1093/jac/dkad008
Published: 20 January 2023
Journal Article
Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 9, September 2022, Pages 2506–2515, https://doi.org/10.1093/jac/dkac207
Published: 28 June 2022
Journal Article
HIV-1-RNA and total HIV-1-DNA loads in the genital compartment in men receiving dolutegravir- versus darunavir-based combined ART (cART) regimens during primary HIV infection
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 3, March 2022, Pages 735–739, https://doi.org/10.1093/jac/dkab427
Published: 23 November 2021
Journal Article
Erratum to: Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 11, November 2021, Page 3070, https://doi.org/10.1093/jac/dkab295
Published: 17 September 2021
Journal Article
Persistent HBV replication and serological response during up to 15 years of tenofovir-based antiretroviral therapy in HIV/HBV-coinfected patients: a multicentre prospective cohort study
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 11, November 2021, Pages 3009–3019, https://doi.org/10.1093/jac/dkab294
Published: 30 August 2021
Journal Article
Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 11, November 2021, Pages 2983–2987, https://doi.org/10.1093/jac/dkab161
Published: 20 May 2021
Journal Article
Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 7, July 2020, Pages 1961–1968, https://doi.org/10.1093/jac/dkaa091
Published: 19 April 2020
Journal Article
Impact of reduced dosing of lopinavir/ritonavir in virologically controlled HIV-infected patients: the Kaledose trial Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 125–128, https://doi.org/10.1093/jac/dkp396
Published: 16 November 2009
Journal Article
Influence of liver fibrosis stage on plasma levels of efavirenz in HIV-infected patients with chronic hepatitis B or C Get access
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 3, March 2009, Pages 579–584, https://doi.org/10.1093/jac/dkn531
Published: 23 January 2009
